Fabio Conforti

Phase II Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Cisplatin-Based Chemotherapy

Paolo Andrea Zucali, Tommaso De Pas, Giovannella Palmieri et al. · Journal of Clinical Oncology · 2017 · 169 citations

Cancer Management, Thymic Carcinoma Previously, Immunology +20

Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy

Christopher P. Vellano, Michael G. White, Miles C. Andrews et al. · Nature · 2022 · 124 citations · Full text

Hormonal Receptor, Breast Cancer, Pharmacotherapy +6

Effect of concomitant medications with immune-modulatory properties on the outcomes of patients with advanced cancer treated with immune checkpoint inhibitors: development and validation of a novel prognostic index

Sebastiano Buti, Melissa Bersanelli, Fabiana Perrone et al. · European Journal of Cancer · 2020 · 111 citations

Advanced Cancer, Medicine, Immune Checkpoint Inhibitors +9

Sex-Based Dimorphism of Anticancer Immune Response and Molecular Mechanisms of Immune Evasion

Fabio Conforti, Laura Pala, Eleonora Pagan et al. · Clinical Cancer Research · 2021 · 101 citations · Full text

Metaplastic breast cancer: Prognostic and therapeutic considerations

Giovanni Corso, Samuele Frassoni, Antonia Girardi et al. · Journal of Surgical Oncology · 2020 · 66 citations